Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NexgenRx Inc (TSE:NXG)
TSXV:NXG
NexgenRx (NXG) Financial Statements
11 Followers
NexgenRx Financial Overview
| Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | C$ 4.29M | C$ 3.57M | C$ 3.39M | C$ 3.42M | C$ 3.46M |
| Gross Profit | C$ 3.40M | C$ 2.75M | C$ 2.66M | C$ 2.67M | C$ 2.74M |
| EBIT | C$ 479.53K | C$ -162.88K | C$ -112.94K | C$ 8.46K | C$ 212.77K |
| EBITDA | C$ 798.33K | C$ 155.76K | C$ 209.09K | C$ 344.93K | C$ 582.83K |
| Net Income Common Stockholders | C$ 460.95K | C$ -387.58K | C$ -130.73K | C$ -8.59K | C$ 194.93K |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | C$ 1.36M | C$ 1.88M | C$ 1.94M | C$ 1.27M | C$ 1.26M |
| Total Assets | C$ 29.29M | C$ 30.20M | C$ 29.44M | C$ 28.85M | C$ 28.60M |
| Total Debt | C$ 447.65K | C$ 461.88K | C$ 399.28K | C$ 410.48K | C$ 421.55K |
| Net Debt | C$ -913.37K | C$ -1.41M | C$ -1.54M | C$ -859.15K | C$ -842.79K |
| Total Liabilities | C$ 21.01M | C$ 22.48M | C$ 20.93M | C$ 20.25M | C$ 19.58M |
| Stockholders Equity | C$ 8.27M | C$ 7.71M | C$ 8.51M | C$ 8.60M | C$ 9.02M |
| Cash Flow | - | ||||
| Free Cash Flow | - | C$ 385.49K | C$ 655.41K | C$ 440.29K | C$ -464.16K |
| Operating Cash Flow | C$ -526.46K | C$ 397.36K | C$ 708.69K | C$ 617.24K | C$ -378.41K |
| Investing Cash Flow | C$ -60.55K | C$ -11.87K | C$ -53.28K | C$ -176.95K | C$ -85.75K |
| Financing Cash Flow | C$ 71.27K | C$ -445.96K | C$ 12.21K | C$ -435.00K | C$ -460.22K |
NexgenRx Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.